← Open Payments lookup

ISABELLA BROWN: Open Payments

NPI 1720779689 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,378 in 117 payments from 28 companies in 2025. Trend: 2023 $32 · 2024 $1,067 · 2025 $2,378

Food & beverage: $2,378
CompanyPaymentsAmount
ABBVIE INC.21$380
Vanda Pharmaceuticals Inc.10$289
Salix Pharmaceuticals, a division of Bausch Health US, LLC12$219
Ardelyx, Inc.9$191
Janssen Biotech, Inc.9$180
Takeda Pharmaceuticals U.S.A., Inc.8$170
Regeneron Healthcare Solutions, Inc.7$143
Madrigal Pharmaceuticals4$115
Braintree Laboratories, Inc.3$81
Lilly USA, LLC5$80

Products named: IBSRELA, DUPIXENT, TREMFYA, HETLIOZ, ENTYVIO, RINVOQ, XIFAXAN, REZDIFFRA.

Industry payments across KY — which companies pay providers there.